{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:23:24Z","timestamp":1761153804050},"reference-count":47,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2016.00054","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T08:25:10Z","timestamp":1465287910000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficient Use of a Crude Drug\/Herb Library Reveals Ephedra Herb As a Specific Antagonist for TH2-Specific Chemokine Receptors CCR3, CCR4, and CCR8"],"prefix":"10.3389","volume":"4","author":[{"given":"Kazuhiko","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsugu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotoshi","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yoshie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1172\/JCI26679","article-title":"Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis","volume":"116","author":"Blanchard","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4172\/2155-9899.1000110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J. Clin. Cell Immunol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.183.5.2349","article-title":"Cloning, expression, and characterization of the human eosinophil eotaxin receptor","volume":"183","author":"Daugherty","year":"1996","journal-title":"J Exp Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/08830189809043004","article-title":"The concept of type-1 and type-2 helper T cells and their cytokines in humans","volume":"16","author":"Del Prete","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.185.12.2171","article-title":"Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes","volume":"185","author":"Forssmann","year":"1997","journal-title":"J. Exp. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1067\/mai.2002.126079","article-title":"Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis","volume":"110","author":"Fujisawa","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"55","key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2015.00055","article-title":"Biomedical insights into cell adhesion and migration-from a viewpoint of central nervous system tumor immunology","volume":"3","author":"Fujita","year":"2015","journal-title":"Front Cell Dev Biol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4049\/jimmunol.163.1.403","article-title":"Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation","volume":"163","author":"Gonzalo","year":"1999","journal-title":"J. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/01902148.2011.587136","article-title":"The effect of influenza virus A on th1\/th2 balance and alveolar fluid clearance in pregnant rats","volume":"37","author":"Gu","year":"2011","journal-title":"Exp. Lung Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1172\/JCI119145","article-title":"Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody","volume":"99","author":"Heath","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1586\/14737175.6.5.795","article-title":"Analgesic treatment with Kampo prescription","volume":"6","author":"Hijikata","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/intimm\/dxf044","article-title":"IFN-gamma-inducible expression of thymus and activation-regulated chemokine\/CCL17 and macrophage-derived chemokine\/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis","volume":"14","author":"Horikawa","year":"2002","journal-title":"Int. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","article-title":"Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4","volume":"273","author":"Imai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2249.2002.01727.x","article-title":"Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis","volume":"127","author":"Kakinuma","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/1346-8138.12440","article-title":"Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis","volume":"41","author":"Kataoka","year":"2014","journal-title":"J. Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.4049\/jimmunol.166.3.2055","article-title":"Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice","volume":"166","author":"Kawasaki","year":"2001","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.1074\/jbc.271.13.7725","article-title":"Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3","volume":"271","author":"Kitaura","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"27975","DOI":"10.1074\/jbc.274.39.27975","article-title":"Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3","volume":"274","author":"Kitaura","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JVI.66.4.1977-1984.1992","article-title":"Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands","volume":"66","author":"Lucin","year":"1992","journal-title":"J. Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1875-5364(14)60044-3","article-title":"Ma Huang Tang ameliorates asthma though modulation of Th1\/Th2 cytokines and inhibition of Th17 cells in ovalbumin-sensitized mice","volume":"12","author":"Ma","year":"2014","journal-title":"Chin. J. Nat. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrneurol.2015.248","article-title":"CCR5 blockade for neuroinflammatory diseases - beyond control of HIV","volume":"12","author":"Martin-Blondel","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10156-012-0378-7","article-title":"A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza","volume":"18","author":"Nabeshima","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.4049\/jimmunol.173.3.2078","article-title":"Liver-expressed chemokine\/CC chemokine ligand 16 attracts eosinophils by interacting with histamine H4 receptor","volume":"173","author":"Nakayama","year":"2004","journal-title":"J. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.4049\/jimmunol.0904126","article-title":"Eotaxin-3\/CC chemokine ligand 26 is a functional ligand for CX3CR1","volume":"185","author":"Nakayama","year":"2010","journal-title":"J. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/all.12782","article-title":"Latest developments in allergic rhinitis in Allergy for clinicians and researchers","volume":"70","author":"Ng","year":"2015","journal-title":"Allergy"},{"key":"B30","first-page":"4425","article-title":"Early-phase treatment by Low-dose 5-Fluorouracil or primary tumor resection inhibits MDSC-mediated lung metastasis formation","volume":"35","author":"Otsubo","year":"2015","journal-title":"Anticancer Res."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3109\/02813432.2016.1160629","article-title":"Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: a systematic review","author":"Pols","year":"2016","journal-title":"Scand. J. Prim. Health Care"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1084\/jem.183.6.2437","article-title":"Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils","volume":"183","author":"Ponath","year":"1996","journal-title":"J. Exp. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science"},{"key":"B34","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.4049\/jimmunol.155.5.2525","article-title":"IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice","volume":"155","author":"Schijns","year":"1995","journal-title":"J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"260235","DOI":"10.1155\/2013\/260235","article-title":"Efficacy of kampo medicine in treating atopic dermatitis: an overview","volume":"2013","author":"Shimizu","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2165\/11631090-000000000-00000","article-title":"Mogamulizumab: first global approval","volume":"72","author":"Subramaniam","year":"2012","journal-title":"Drugs"},{"key":"B37","author":"The Ministry of Health","year":"2011","journal-title":"The Japanese Pharmacopoeia, 16th Edn., English Version"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI119624","article-title":"High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines","volume":"100","author":"Uguccioni","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1172\/JCI7613","article-title":"Overproduction of Th2-specific chemokines in NC\/Nga mice exhibiting atopic dermatitis-like lesions","volume":"104","author":"Vestergaard","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0079-6468(05)43007-6","article-title":"The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS","volume":"43","author":"Wood","year":"2005","journal-title":"Prog. Med. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","article-title":"Type 2 cytokines: mechanisms and therapeutic strategies","volume":"15","author":"Wynn","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1189\/jlb.68.4.568","article-title":"Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells","volume":"68","author":"Yamamoto","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0122458","DOI":"10.1371\/journal.pone.0122458","article-title":"Erythropoietin receptor antagonist suppressed ectopic hemoglobin synthesis in xenografts of HeLa cells to promote their destruction","volume":"10","author":"Yasuda","year":"2015","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0014-5793(99)01114-X","article-title":"Molecular cloning of mXCR1, the murine SCM-1\/lymphotactin receptor","volume":"458","author":"Yoshida","year":"1999","journal-title":"FEBS Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0065-2776(01)78002-9","article-title":"Chemokines in immunity","volume":"78","author":"Yoshie","year":"2001","journal-title":"Adv. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T19:50:19Z","timestamp":1692388219000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fcell.2016.00054\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3389\/fcell.2016.00054","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}